siRNA treatment decreases triglycerides in individuals with uncommon problem

.RESEARCH EMPHASIZE.19 September 2024.

Plozasiran minimized triglyceride levels by 80% and also decreased the risk of pancreatitis in clients along with consistent chylomicronemia, with or even without a hereditary prognosis.